The modality detected more deadly cancers and achieved a better recall rate than traditional mammography, according to Penn researchers.

Engineers from Dartmouth University also said their approach would cut out the need for gadolinium-based contrast agents.

“This study shows a disheartening rate of inadequate exams among mpMRI studies of the prostate,” experts wrote in Academic Radiology.

Abbreviated breast MRI is promising, but must also overcome concerns related to cost and access, one expert noted in an editorial accompanying a new JAMA study.

While the field continues to make technology-centered advances, it must remember to think about the patient's daily struggle with the deadly disease, an expert wrote Feb. 24 in JACR.

Researchers analyzed Medicare claims data on more than 1 million women ages 70 to 84 to reach their conclusions.

A recent review of pivotal cancer drug trials suggests that CVD and adverse cardiovascular outcomes are underreported in studies of new cancer therapies, despite an increasing risk of cardiotoxicity in oncological drugs.

With estimates from the American Cancer Society, implementing this intervention could save between 30,000 and 60,000 lives in the U.S. each year.